Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Aura Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +11 vs. Q1 2022
- Shares held
- 15.8M
- +2.09M (+15.3%) vs. Q1 2022
- Total value
- $223.8M
- −$74.9M (−25.1%) vs. Q1 2022
- New holders
- 11
- 24 more added
- Sold out
- 0
- 5 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 4,112,870 | $58.3M | 1.32% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $43.1M | 17.89% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,312,159 | $32.8M | 0.04% | −4,494−0.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,276,619 | $18.1M | 0.04% | −20,400−1.6% | Reduced |
| Rock Springs Capital Management LP | 1,008,814 | $14.3M | 0.42% | +700+0.1% | Added |
| BlackRock Inc. | 886,723 | $12.6M | 0.00% | +611,696+222.4% | Added |
| FMR LLC | 603,471 | $8.55M | 0.00% | +109,362+22.1% | Added |
| Vanguard Group Inc | 435,175 | $6.17M | 0.00% | +206,542+90.3% | Added |
| Nantahala Capital Management, LLC | 343,215 | $4.86M | 0.42% | +41,225+13.7% | Added |
| State Street Corp | 256,746 | $3.64M | 0.00% | +171,764+202.1% | Added |
| Regency Capital Management Inc. | 254,622 | $3.61M | 3.88% | +254,622 | New |
| Decheng Capital Management III (Cayman), LLC | 210,000 | $2.98M | 1.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 207,294 | $2.94M | 0.00% | +101,960+96.8% | Added |
| Northern Trust Corp | 132,692 | $1.88M | 0.00% | +86,621+188.0% | Added |
| Citigroup Inc | 123,188 | $1.75M | 0.00% | +122,969+56,150.2% | Added |
| UBS Oconnor LLC | 90,539 | $1.28M | 0.01% | +90,539 | New |
| Allianz Asset Management GmbH | 61,575 | $873.0K | 0.00% | +6,430+11.7% | Added |
| Nuveen Asset Management, LLC | 61,227 | $868.0K | 0.00% | +61,227 | New |
| Morgan Stanley | 54,539 | $772.0K | 0.00% | +53,430+4,817.9% | Added |
| Charles Schwab Investment Management Inc | 43,009 | $610.0K | 0.00% | +27,630+179.7% | Added |
| Barclays PLC | 42,186 | $598.0K | 0.00% | −17,511−29.3% | Reduced |
| Bank of New York Mellon Corp | 40,096 | $569.0K | 0.00% | +25,600+176.6% | Added |
| Bank of America Corp | 35,343 | $501.0K | 0.00% | +23,486+198.1% | Added |
| Millennium Management LLC | 22,917 | $325.0K | 0.00% | +22,917 | New |
| Rhumbline Advisers | 20,713 | $294.0K | 0.00% | +20,713 | New |
| UBS Group AG | 16,320 | $231.0K | 0.00% | +15,566+2,064.5% | Added |
| Water Island Capital LLC | 14,541 | $206.0K | 0.01% | +14,541 | New |
| New York State Common Retirement Fund | 14,352 | $203.0K | 0.00% | +8,100+129.6% | Added |
| Captrust Financial Advisors | 13,414 | $190.0K | 0.00% | +13,414 | New |
| MetLife Investment Management | 11,026 | $156.2K | 0.00% | +11,026 | New |
| JPMorgan Chase & Co | 9,798 | $139.0K | 0.00% | +7,170+272.8% | Added |
| Deutsche Bank AG | 9,261 | $131.0K | 0.00% | +6,311+213.9% | Added |
| American International Group, Inc. | 8,577 | $122.0K | 0.00% | +5,795+208.3% | Added |
| California State Teachers Retirement System | 7,836 | $111.0K | 0.00% | +5,478+232.3% | Added |
| Tower Research Capital LLC (TRC) | 3,949 | $56.0K | 0.00% | +2,840+256.1% | Added |
| Amalgamated Bank | 2,896 | $41.0K | 0.00% | +2,105+266.1% | Added |
| Ameritas Investment Partners, Inc. | 1,374 | $19.0K | 0.00% | +953+226.4% | Added |
| Metropolitan Life Insurance Co | 1,280 | $18.1K | 0.00% | +1,280 | New |
| STRS Ohio | 1,300 | $18.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 862 | $12.0K | 0.00% | +360+71.7% | Added |
| Clear Street Markets LLC | 750 | $11.0K | 0.00% | +750 | New |
| Wells Fargo & Company | 430 | $6.00K | 0.00% | −791−64.8% | Reduced |
| Royal Bank of Canada | 103 | $1.00K | 0.00% | −242−70.1% | Reduced |
| Credit Suisse AG | 12 | $0 | 0.00% | +12 | New |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |